Atlas Legacy Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 2054111 LOS ANGELES, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$656,025

+$288,468 QoQ

Shares Held

2,607

+54.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#2,923

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 66% Shared 34% None 0%

Healthcare · as of Jun 30, 2026

Atlas Legacy Advisors, LLC holds $5,121,297 across 6 Drug Manufacturers - General names. ABBV ranks #3 (12.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,579	$1,893,899
2	JNJ	Johnson & Johnson	4,361	$1,107,562
3	ABBV	AbbVie Inc. This page	2,607	$656,025
4	AMGN	Amgen Inc	1,644	$595,324
5	MRK	Merck & Co., Inc.	4,578	$588,272
6	NVS	Novartis AG	1,788	$280,215

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$656,025	2,607	+54.3%	Shares	Sole	2026-07-31
2026-03-31	$367,557	1,690	-30.7%	Shares	Other	2026-05-11
2025-12-31	$557,286	2,439	+3.5%	Shares	Other	2026-01-29
2025-09-30	$545,507	2,356	+83.8%	Shares	Other	2025-10-30
2025-06-30	$237,964	1,282	+21.7%	Shares	Sole	2025-08-06
2025-03-31	$220,624	1,053	-34.7%	Shares	Sole	2025-05-07
2024-12-31	$286,630	1,613	—	Shares	Sole	2025-01-31
No filing history on record for this holder in this stock.